Effects of Exenatide on Coagulation and Platelet Aggregation in Patients with Type 2 Diabetes
Yaqin Zhang,1,* Ruofei Chen,1,* Yangyang Jia,2 Mingwei Chen,2 Zongwen Shuai1 1Department of Rheumatology, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, People’s Republic of China; 2Department of Endocrinology, The First Affiliated Hospital of Anhui Medical...
Main Authors: | Zhang Y, Chen R, Jia Y, Chen M, Shuai Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/effects-of-exenatide-on-coagulation-and-platelet-aggregation-in-patien-peer-reviewed-fulltext-article-DDDT |
Similar Items
-
Pharmalogical effects and results of clinical trials of the first incretinomimetic exenatide
by: Alexander Sergeevich Ametov, et al.
Published: (2011-09-01) -
Effects of a 6-Month Exenatide Therapy on HbA1c and Weight in Korean Patients with Type 2 Diabetes: A Retrospective Cohort Study
by: Juyoung Shin, et al.
Published: (2012-10-01) -
Unexpected bleeding after Exenatide treatment: a causative relationship or a coincidence?
by: Khoury Johad, et al.
Published: (2018-07-01) -
The GLP-1 Receptor Agonist Exenatide Ameliorates Bone Composition and Tissue Material Properties in High Fat Fed Diabetic Mice
by: Sity Aishah Mansur, et al.
Published: (2019-02-01) -
Clinical Application of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus
by: Young Min Cho, et al.
Published: (2013-12-01)